Amersham International's range of non-radioactive products grows in importance with the introduction of its innovative Amerlite™ immunoassay system, which was based on enhanced chemiluminescence and included instruments as well as reagents. By the mid-80s, the company employs around 3000 people and annual sales top £100 million.